Corium Innovations, Inc. clinical trials
Formerly part of Corium, Inc., Oct 2022 · source ↗
The registry lists 6 studies whose lead sponsor is Corium Innovations, Inc.. 1 are recruiting or about to start. Per ClinicalTrials.gov, last updated Oct 1, 2026.
Before and after it left Corium, Inc.
- First submitted before Corium Innovations, Inc. left Corium, Inc.
- 0
- First submitted after Corium Innovations, Inc. left Corium, Inc.
- 6
- Unclear, or no submission date
- 0
By the date each study was first submitted to the registry. The registry lists today's sponsor name and keeps no history, so this says when a study was filed, not who filed it.
Phase
- Phase 1
- 4
Registry sponsor names on this page
- Corium Innovations, Inc.6 studies
Something wrong with this grouping? Tell us on the Corium, Inc. page.
Studies
Recruiting first, then most recently updated. Showing 6 of 6. All Corium, Inc. studies →
- A Study to Assess the Skin Irritation and Sensitization of Estradiol/Levonorgestrel TDS in Healthy Postmenopausal SubjectsRecruitingNCT07794150Phase 1
Sponsor listed in the registry: Corium Innovations, Inc. · First submitted after Corium Innovations, Inc. left Corium, Inc.
- A Study to Assess the Bioavailability and Adhesion of Estradiol/Levonorgestrel TDS in Healthy Post-Menopausal Female ParticipantsActive, not recruitingNCT07851649Phase 1
Sponsor listed in the registry: Corium Innovations, Inc. · First submitted after Corium Innovations, Inc. left Corium, Inc.
- A Study to Assess the Skin Irritation and Sensitization of Selegiline TDS in Healthy SubjectsActive, not recruitingNCT07452692Phase 1
Sponsor listed in the registry: Corium Innovations, Inc. · First submitted after Corium Innovations, Inc. left Corium, Inc.
- A Study to Assess the Bioavailability and Adhesion of Selegiline TDS in Healthy SubjectsCompletedNCT07571824Phase 1
Sponsor listed in the registry: Corium Innovations, Inc. · First submitted after Corium Innovations, Inc. left Corium, Inc.
- Determine PK Profiles of Ozanimod and Its' Major Metabolites in Healthy SubjectsCompletedNCT06528665
Sponsor listed in the registry: Corium Innovations, Inc. · First submitted after Corium Innovations, Inc. left Corium, Inc.
- Determine the Bioavailability of Selegiline TDS 6mg/24 Hours vs EMSAM in Healthy SubjectsCompletedNCT06607744
Sponsor listed in the registry: Corium Innovations, Inc. · First submitted after Corium Innovations, Inc. left Corium, Inc.